Neuroscience & Neuroimaging Research Collection

Journal article

Efficacy and moderators of mindfulness-based cognitive therapy (MBCT) in prevention of depressive relapse: An individual patient data meta-analysis from randomized trials

Abstract:: Importance: Relapse prevention in recurrent depression is a significant public health problem, and antidepressants are the current first-line treatment approach. Identifying an equally efficacious nonpharmacological intervention would be an important development.
Objective: To conduct a meta-analysis on individual patient data to examine... Expand abstract
Collapse abstract

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Kuyken, W., Warren, F., Taylor, R., Whalley, B., Crane, C., Bondolfi, G., Hayes, R., Huijbers, M., Ma, H., Schweizer, S., Segal, Z., Speckens, A., Teasdale, J., Van Heeringen, K., Williams, M., Byford, S., Byng, R., & Dalgleish, T. (2016). Efficacy and moderators of mindfulness-based cognitive therapy (MBCT) in prevention of depressive relapse: An individual patient data meta-analysis from randomized trials. JAMA Psychiatry, 73(6), 565–574.

MLA Style

Kuyken, W, et al. “Efficacy and Moderators of Mindfulness-Based Cognitive Therapy (MBCT) in Prevention of Depressive Relapse: An Individual Patient Data Meta-Analysis from Randomized Trials.” JAMA Psychiatry, vol. 73, no. 6, 2016, pp. 565–74.

Chicago Style

Kuyken, W, F Warren, R Taylor, et al. 2016. “Efficacy and Moderators of Mindfulness-Based Cognitive Therapy (MBCT) in Prevention of Depressive Relapse: An Individual Patient Data Meta-Analysis from Randomized Trials.” JAMA Psychiatry 73 (6): 565–74.
Print

Access Document

Files:: yoi160005.pdf

(Preview, Version of record, pdf, 450.5KB, Terms of use)

Publisher copy:: 10.1001/jamapsychiatry.2016.0076

Authors

+ Kuyken, W More by this author

Institution:: University of Oxford
Division:: MSD
Department:: Psychiatry
Role:: Author

+ Warren, F More by this author

Role:: Author

+ Taylor, R More by this author

Role:: Author

+ Whalley, B More by this author

Role:: Author

+ Crane, C More by this author

Institution:: University of Oxford
Division:: MSD
Department:: Psychiatry
Role:: Author

More authors...

+ Wellcome Trust More from this funder

Grant:: 104908/Z/14/Z

+ National Institute of Health Research More from this funder

Publisher:: American Medical Association
Journal:: JAMA Psychiatry More from this journal
Volume:: 73
Issue:: 6
Pages:: 565-574
Publication date:: 2016-04-27
Acceptance date:: 2016-01-15
DOI:: 10.1001/jamapsychiatry.2016.0076
EISSN:: 2168-6238
ISSN:: 2168-622X

Pubs id:: pubs:593530
UUID:: uuid:9f41e9b4-2d2d-4317-818f-d850adda08f5
Local pid:: pubs:593530
Source identifiers:: 593530
Deposit date:: 2016-01-21
ARK identifier:: ark:/29072/ora_9f41e9b42d2d4317818fd850adda08f5

Terms of use

Copyright holder:: American Medical Association
Copyright date:: 2016
Notes:: © 2016 American Medical Association

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP